Search results
Results from the WOW.Com Content Network
Unilab, Inc., commonly known as Unilab (stylized in all caps), is a Philippine pharmaceutical company headquartered in Mandaluyong, Metro Manila. [1] It specializes in a wide range of consumer healthcare products such as prescription and over-the counter medications, vitamins and food supplements, and biotechnology.
The Liusons, a traditional Chinese family has been involved in the pharmaceutical industry since 1959 through Pacific Pharma, an importer and wholesaler of drugs. [3] In 1983, Pacific Pharma shifted to investing on generic drugs. [3] The company initially largely sold generic drugs wholesale to government hospitals. [4]
The Cathay Drug Company operates exclusively in the Philippines. Its main area of specialization is the marketing and distribution of pharmaceutical drugs and products for both humans and animals. The company acquires its products through licensing agreements with domestic and international firms. Among its main suppliers are the following:
For premium support please call: 800-290-4726 more ways to reach us
Location of the Philippines. The Philippines is a sovereign island country in Southeast Asia situated in the western Pacific Ocean. It is a founding member of the United Nations, World Trade Organization, Association of Southeast Asian Nations, the Asia-Pacific Economic Cooperation forum, and the East Asia Summit.
No. 4: Eli Lilly, 3.5% dividend yield Eli Lilly's 3.5% dividend ranks fourth in big pharma, and the company's dividend history is appealing -- until you reach 2009. For the first decade of the ...
If you want to see more stocks in this selection, check out 5 Best Pharma Dividend Stocks To Buy. As per a Bloomberg report dated September 12, the global bio-pharma market was valued at $274.10 ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.